Healthcare & Life Sciences
Fusion Pharmaceuticals
United States
acquiredacquired
acquired
Stage
2
Investors
About
Fusion Pharmaceuticals develops next-generation radiopharmaceuticals that deliver targeted alpha therapy to treat cancer with precision medicine approaches.
Explore Fusion Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.